Common Genetic Variants of the Human Steroid 21-Hydroxylase Gene (CYP21A2) Are Related to Differences in Circulating Hormone Levels

Purpose Systematic evaluation of the potential relationship between the common genetic variants of CYP21A2 and hormone levels. Methods The relationships of CYP21A2 intron 2 polymorphisms and haplotypes with diverse baseline and stimulated blood hormone levels were studied in 106 subjects with non-functioning adrenal incidentaloma (NFAI). The rationale for using NFAI subjects is dual: i) their baseline hormone profiles do not differ from those of healthy subjects and ii) hormone levels after stimulation tests are available. Results The carriers (N = 27) of a well-defined CYP21A2 haplotype cluster (c5) had significantly elevated levels of cortisol (p = 0.0110), and 17-hydroxyprogesterone (p = 0.0001) after ACTH stimulation, and 11-deoxycortisol after metyrapone administration (p = 0.0017), but the hormone values were in normal ranges. In addition, the carriers (N = 33) of the C allele of the rs6462 polymorphism had a higher baseline aldosterone level (p = 0.0006). The prevalence of these genetic variants of CYP21A2 did not differ between NFAI and healthy subjects. Conclusions The common CYP21A2 variants presumably exert the same effect on hormone levels in the healthy and disease-affected populations. Therefore, they may contribute to complex diseases such as some cardiovascular diseases, and may influence the genotype-phenotype correlation in patients with congenital adrenal hyperplasia (CAH) including the individual need for hormone substitution.

[1]  R. Auchus,et al.  Approach to the patient: the adult with congenital adrenal hyperplasia. , 2013, The Journal of clinical endocrinology and metabolism.

[2]  Z. Doleschall,et al.  Both Positive and Negative Selection Pressures Contribute to the Polymorphism Pattern of the Duplicated Human CYP21A2 Gene , 2013, PloS one.

[3]  G. Prévost,et al.  Autocrine/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism. , 2013, European journal of endocrinology.

[4]  T. Yuen,et al.  Genotype–phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency , 2013, Proceedings of the National Academy of Sciences.

[5]  J. Szabó,et al.  Intraspecific Evolution of Human RCCX Copy Number Variation Traced by Haplotypes of the CYP21A2 Gene , 2012, Genome biology and evolution.

[6]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[7]  Á. Szilágyi,et al.  Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes , 2012, Genes and Immunity.

[8]  K. Rácz,et al.  ACTH‐induced cortisol release is related to the copy number of the C4B gene encoding the fourth component of complement in patients with non‐functional adrenal incidentaloma , 2012, Clinical endocrinology.

[9]  S. Tsagarakis,et al.  Endocrine incidentalomas—challenges imposed by incidentally discovered lesions , 2011, Nature Reviews Endocrinology.

[10]  S. Siegelman,et al.  Medical and surgical evaluation and treatment of adrenal incidentalomas. , 2011, The Journal of clinical endocrinology and metabolism.

[11]  W. Miller,et al.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.

[12]  P. Igaz,et al.  Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome , 2011, Steroids.

[13]  L. Excoffier,et al.  Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows , 2010, Molecular ecology resources.

[14]  Tomas W. Fitzgerald,et al.  Origins and functional impact of copy number variation in the human genome , 2010, Nature.

[15]  Pablo Librado,et al.  DnaSP v5: a software for comprehensive analysis of DNA polymorphism data , 2009, Bioinform..

[16]  Daniel W. Jones,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[17]  N. Sonino,et al.  The role of 21-hydroxylase in the pathogenesis of adrenal masses: Review of the literature and focus on our own experience , 2007, Journal of endocrinological investigation.

[18]  G. Thorgeirsson,et al.  Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality , 2007, Clinical and experimental immunology.

[19]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[20]  W. Young.  The incidentally discovered adrenal mass , 2007 .

[21]  W. Young.  Clinical practice. The incidentally discovered adrenal mass. , 2007, The New England journal of medicine.

[22]  D. Balding.  A tutorial on statistical methods for population association studies , 2006, Nature Reviews Genetics.

[23]  Z. Rónai,et al.  Rapid quantification of human complement component C4A and C4B genes by capillary gel electrophoresis , 2006, Electrophoresis.

[24]  Z. Rónai,et al.  Real-time PCR quantification of human complement C4A and C4B genes , 2006, BMC Genetics.

[25]  Alan R. Templeton,et al.  TreeScan: a bioinformatic application to search for genotype/phenotype associations using haplotype trees , 2005, Bioinform..

[26]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[27]  J. Kramer,et al.  A marked drop in the incidence of the null allele of the B gene of the fourth component of complement (C4B*Q0) in elderly subjects: C4B*Q0 as a probable negative selection factor for survival , 1991, Human Genetics.

[28]  Christiane,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2004, Journal international de bioethique = International journal of bioethics.

[29]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[30]  M. Hoehe,et al.  Haplotypes and the systematic analysis of genetic variation in genes and genomes. , 2003, Pharmacogenomics.

[31]  H. Smeets,et al.  Mapping of a de novo unequal crossover causing a deletion of the steroid 21-hydroxylase (CYP21A2) gene and a non-functional hybrid tenascin-X (TNXB) gene , 2003, Journal of medical genetics.

[32]  T. Hoogenboezem,et al.  Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes , 2002, Human Genetics.

[33]  K. Rácz,et al.  Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. , 2002, European journal of endocrinology.

[34]  W. Waldhäusl,et al.  Increased prevalence of heterozygous 21‐OH germline mutations in patients with adrenal incidentalomas , 2002, Clinical endocrinology.

[35]  Wolzt,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2003, The Journal of the American College of Dentists.

[36]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[37]  P. White,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2000, Endocrine reviews.

[38]  R. Kiss,et al.  Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy , 2000, Journal of endocrinological investigation.

[39]  G. Arnaldi,et al.  A Survey on Adrenal Incidentaloma in Italy , 2000 .

[40]  G. Arnaldi,et al.  A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. , 2000, The Journal of clinical endocrinology and metabolism.

[41]  T. R. Welch,et al.  Modular Variations of the Human Major Histocompatibility Complex Class III Genes for Serine/Threonine Kinase RP, Complement Component C4, Steroid 21-Hydroxylase CYP21, and Tenascin TNX (the RCCX Module) , 1999, The Journal of Biological Chemistry.

[42]  W. Scherbaum,et al.  Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. , 1998, Endocrine reviews.

[43]  F. Pinet,et al.  Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and "nonfunctioning" adrenal adenomas. , 1993, The Journal of clinical endocrinology and metabolism.

[44]  J. Bauer.  Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications. , 1993, Drugs & aging.

[45]  O. Gotoh,et al.  Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[46]  T. Diperri,et al.  Aldosterone in congestive heart failure. , 1959, Acta medica Scandinavica.